Lung Cancer News and Research

Latest Lung Cancer News and Research

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce the size of their tumours, suggests a randomised trial published online today by The Lancet Oncology.

17 May 2005

Significant non-coronary findings found during heart CT scans point to importance of trained radiologists

A significant percentage of patients undergoing targeted CT of the heart have abnormalities outside the coronary arteries, some of which could be life threatening, and as a result need the experience of trained radiologists to interpret them, say researchers from the University of Michigan Cardiovascular Center in Ann Arbor.

16 May 2005

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Five-year data from a study evaluating the use of docetaxel (Taxotere) administered after cisplatin/etoposide chemotherapy plus radiation therapy demonstrate the best long-term survival rates reported in patients with locally advanced (Stage IIIB) non-small cell lung cancer (NSCLC).

16 May 2005

Vaccine candidate to treat nicotine addiction shows promise

Cytos Biotechnology AG has announced that its vaccine candidate CYT002-NicQb to treat nicotine addiction has achieved proof of efficacy.

16 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Zometa reduces bone loss in patients receiving breast cancer treatment

Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).

16 May 2005

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.

15 May 2005

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

15 May 2005

Hispanics have worse lung cancer survival rate

In a national population-based study of 16,036 lung cancer patients, Hispanics with curable stage I lung cancer had poorer lung cancer specific survival rates, as well as worse all-cause mortality, than a much larger group of white persons. Study results will appear in the second issue for May 2005 of the American Thoracic Society's peer-reviewed American Journal of Respiratory and Critical Care Medicine.

15 May 2005

First advance in pancreatic cancer treatment in a decade offers new hope

The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.

15 May 2005

If you want to avoid smoke-filled pubs you will be better off in the south of England

If you want to avoid smoke-filled pubs you will be better off in the south of England than in the north according to a snapshot survey published today by the British Medical Association (BMA). In an attempt to establish just how many pubs will be exempt from laws banning smoking in enclosed workplaces, the BMA found wide regional differences with a strong north-south divide.

12 May 2005

Major Northern Ireland survey to seek public views on cancer

A major postal survey which will help raise cancer awareness is being conducted by the University of Ulster and funded by the Ulster Cancer Foundation.

10 May 2005

Many lives may be saved by new blood test for ovarian cancer

A new blood test which has the potential to save many lives has been developed to detect ovarian cancer, a disease known as the silent killer because it is so difficult to identify.

9 May 2005

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Patients with advanced non–small-cell lung cancer (NSCLC) whose tumor cells contain extra copies of the epidermal growth factor receptor (EGFR) gene may be more likely to respond to the drug gefitinib (Iressa), and this high gene copy number may be an effective predictor of gefitinib efficacy, according to a new study in the May 4 issue of the Journal of the National Cancer Institute.

3 May 2005

Critical lock and key mechanism found for the assembly of tumor blood vessels

A critical lock and key mechanism that allows the final step in the completion of new blood vessel formation has been identified by a University of California, San Diego (UCSD) School of Medicine team in research that promises to lead to a new way to halt tumor growth by cutting off the tumor blood supply.

3 May 2005

British Medical Association on the attack over smoking myths by pro-smokers groups

The British Medical Association (BMA) has published a report aimed at the "myths" it said the pro-smoking lobby had told to oppose legislation. Doctors are claiming that AMs have been told 'myths' about a smoking ban and they have now have stepped up their campaign to see the Welsh assembly call for a smoking ban in Wales.

1 May 2005

New report clears the air on the smoking debate

The British Medical Association publishes a report today that will clear the air on the smoking debate. The report, 'Behind the smokescreen', backs up the BMA's call for a UK-wide ban on smoking in all enclosed public places.

28 Apr 2005

Elderly lung cancer patients tolerate combined chemotherapy and radiotherapy with no higher risk of death than younger patients

Lung cancer remains the leading cause of cancer deaths in the U.S., with half of those diagnosed at age 70 years or older. About 20 percent of patients with lung cancer will have small cell lung cancer (SCLC). In the past, SCLC progressed rapidly despite initial chemotherapy sensitivity and few patients survive three years.

25 Apr 2005

Breakthrough technology that identifies molecular markers in early lung cancer

The new technology, created in collaboration with SEQUENOM, developers of genetic analysis products, and Methexis Genomics, uses a DNA analysis technique called methylation profiling to detect cells in the lung that are likely to become cancerous.

23 Apr 2005

ASTRO public awareness campaign wins award

The American Society for Therapeutic Radiology and Oncology’s public awareness campaign to educate cancer patients on their treatment options has won an Award of Distinction from The Communicator Awards in their 2005 Print Media competition. ASTRO also received Awards of Distinction for its quarterly magazine, ASTROnews, and its Annual Meeting Guide magazine supplement.

20 Apr 2005

Lung Cancer News and Research

Latest Lung Cancer News and Research

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Significant non-coronary findings found during heart CT scans point to importance of trained radiologists

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Vaccine candidate to treat nicotine addiction shows promise

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Zometa reduces bone loss in patients receiving breast cancer treatment

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Hispanics have worse lung cancer survival rate

First advance in pancreatic cancer treatment in a decade offers new hope

If you want to avoid smoke-filled pubs you will be better off in the south of England

Major Northern Ireland survey to seek public views on cancer

Many lives may be saved by new blood test for ovarian cancer

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Critical lock and key mechanism found for the assembly of tumor blood vessels

British Medical Association on the attack over smoking myths by pro-smokers groups

New report clears the air on the smoking debate

Elderly lung cancer patients tolerate combined chemotherapy and radiotherapy with no higher risk of death than younger patients

Breakthrough technology that identifies molecular markers in early lung cancer

ASTRO public awareness campaign wins award

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in